{"id":13906,"date":"2020-06-03T12:15:41","date_gmt":"2020-06-03T12:15:41","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/"},"modified":"2026-02-11T09:47:21","modified_gmt":"2026-02-11T09:47:21","slug":"sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology","status":"publish","type":"post","link":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/","title":{"rendered":"Sygnature renforce ses capacit\u00e9s avec l’acquisition d’Alderley Oncology"},"content":{"rendered":"

Excellente nouvelle\u00a0! Chez Sygnature Discovery, nous renfor\u00e7ons encore nos capacit\u00e9s en oncologie et immuno-oncologie gr\u00e2ce \u00e0 l\u2019acquisition d\u2019Alderley Oncology, un prestataire de services sp\u00e9cialis\u00e9 en pharmacologie in vivo<\/em> qui propose des services in vivo<\/em> de haute qualit\u00e9 pour la d\u00e9couverte de m\u00e9dicaments anticanc\u00e9reux.<\/p>\n

Cette acquisition permettra \u00e0 Sygnature de b\u00e9n\u00e9ficier d\u2019une expertise interne significative dans la conception, la r\u00e9alisation et l\u2019interpr\u00e9tation d\u2019\u00e9tudes pharmacologiques in vivo<\/em> pivotales en oncologie, contribuant ainsi \u00e0 identifier des candidats pr\u00e9cliniques prometteurs. Ces \u00e9valuations permettent \u00e9galement de d\u00e9finir la strat\u00e9gie th\u00e9rapeutique et d\u2019identifier les populations de patients susceptibles de mieux r\u00e9pondre au traitement. <\/p>\n

Alderley Oncology a \u00e9t\u00e9 fond\u00e9e par Jane Kendrew en 2017. Jane et son \u00e9quipe poss\u00e8dent une vaste exp\u00e9rience dans le domaine, acquise en grande partie chez AstraZeneca. \u00ab Nous sommes ravis de rejoindre Sygnature Discovery \u00bb, a d\u00e9clar\u00e9 Jane Kendrew. \u00ab Nous avons h\u00e2te de travailler au sein d\u2019une \u00e9quipe pleinement int\u00e9gr\u00e9e, au service de la communaut\u00e9 de la recherche en oncologie et immuno-oncologie, avec pour objectif ultime d\u2019aider les patients atteints de cancer. \u00bb <\/p>\n

\"L'\u00e9quipe<\/p>\n

\u00ab Nous sommes ravis d\u2019accueillir Jane et Alderley Oncology au sein de Sygnature Discovery \u00bb, d\u00e9clare le Dr Stuart Onions, directeur de la gestion de la recherche chez Sygnature. \u00ab L\u2019expertise de l\u2019\u00e9quipe en oncologie et en mod\u00e8les in vivo<\/em> d\u2019immuno-oncologie renforcera consid\u00e9rablement notre offre int\u00e9gr\u00e9e en oncologie, apportant une valeur ajout\u00e9e \u00e0 nos projets int\u00e9gr\u00e9s pour nos clients et, surtout, nous permettant d\u2019acc\u00e9l\u00e9rer et de d\u00e9velopper plus efficacement de nouvelles th\u00e9rapies potentielles en phase pr\u00e9clinique. \u00bb <\/p>\n

Cette transaction compl\u00e8te l\u2019acquisition en 2018 de RenaSci<\/a> , bas\u00e9e \u00e0 Nottingham, qui a apport\u00e9 aux services in vitro<\/em> de Sygnature une expertise in vivo<\/em> compl\u00e9mentaire dans les domaines de l\u2019abus et de la d\u00e9pendance, des maladies m\u00e9taboliques, des troubles du SNC et des maladies du foie et des reins. Nous sommes d\u00e9sormais en mesure d\u2019offrir \u00e0 nos clients une gamme compl\u00e8te de tests de laboratoire in vitro<\/em> et in vivo<\/em> , ainsi qu\u2019une contribution intellectuelle consid\u00e9rable dans la d\u00e9couverte de m\u00e9dicaments anticanc\u00e9reux. Cela \u00e9tend \u00e9galement la pr\u00e9sence de Sygnature \u00e0 Alderley Park, o\u00f9 nous avons actuellement une partie de notre d\u00e9partement DMPK<\/a> .<\/p>\n

Le Dr Simon Hirst, PDG de Sygnature, a ajout\u00e9 que ces nouvelles comp\u00e9tences permettront \u00e0 notre entreprise de consolider son succ\u00e8s aupr\u00e8s de ses clients. \u00ab L\u2019acquisition d\u2019Alderley Oncology \u00e9largit et renforce notre offre de services de d\u00e9couverte de m\u00e9dicaments et dynamise nos investissements continus en oncologie \u00bb, a-t-il d\u00e9clar\u00e9. \u00ab Nous avons d\u00e9j\u00e0 livr\u00e9 cinq candidats pr\u00e9cliniques en oncologie \u00e0 nos clients. Sygnature dispose d\u2019un portefeuille croissant de programmes int\u00e9gr\u00e9s en oncologie et immuno-oncologie, avec des clients aux \u00c9tats-Unis et en Europe. L\u2019expertise suppl\u00e9mentaire acquise gr\u00e2ce \u00e0 Alderley Oncology contribuera grandement \u00e0 faire progresser ces projets vers le d\u00e9veloppement pr\u00e9clinique. \u00bb <\/p>\n

\"\"<\/p>\n

Le Dr Kath Mackay, directrice g\u00e9n\u00e9rale de Bruntwood SciTech \u2013 Alderley Park, a ajout\u00e9\u00a0: \u00ab\u00a0Nous sommes tr\u00e8s fiers du travail remarquable accompli par Jane et son \u00e9quipe ces trois derni\u00e8res ann\u00e9es pour cr\u00e9er Alderley Oncology et en faire une entreprise florissante. Le moment est venu, avec le soutien de Sygnature, de prendre de l\u2019ampleur et d\u2019acc\u00e9l\u00e9rer sa croissance afin de jouer un r\u00f4le encore plus crucial dans le d\u00e9veloppement de l\u2019oncologie au Royaume-Uni et dans le monde.\u00a0\u00bb<\/p>\n

Pour toute question ou pour en savoir plus sur Sygnature Discovery, nos services en oncologie, en recherche in vivo<\/em> ou sur la d\u00e9couverte de m\u00e9dicaments en g\u00e9n\u00e9ral, n\u2019h\u00e9sitez pas \u00e0 nous contacter. Vous pouvez nous joindre via l\u2019un de nos formulaires de contact.<\/u><\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":13907,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"category":[949,823,816],"tags":[824,825,1151,827,1149,1013,1150],"class_list":["post-13906","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-modeles-doncologie","category-oncologie","category-pharmacologie-in-vivo","tag-decouverte-de-la-signature","tag-decouverte-de-medicaments","tag-experiences-precliniques","tag-oncologie","tag-oncologie-dalderley","tag-pharmacologie-in-vivo","tag-recherche-sur-le-cancer"],"acf":[],"yoast_head":"\nSygnature renforce ses capacit\u00e9s avec l'acquisition d'Alderley Oncology - Sygnature<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sygnature renforce ses capacit\u00e9s avec l'acquisition d'Alderley Oncology - Sygnature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-03T12:15:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-11T09:47:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/AO-acquisition-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"pnpd-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"pnpd-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/\"},\"author\":{\"name\":\"pnpd-admin\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\"},\"headline\":\"Sygnature renforce ses capacit\u00e9s avec l’acquisition d’Alderley Oncology\",\"datePublished\":\"2020-06-03T12:15:41+00:00\",\"dateModified\":\"2026-02-11T09:47:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/\"},\"wordCount\":665,\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/AO-acquisition-scaled-1.jpg\",\"keywords\":[\"D\u00e9couverte de la signature\",\"D\u00e9couverte de m\u00e9dicaments\",\"Exp\u00e9riences pr\u00e9cliniques\",\"Oncologie\",\"Oncologie d'Alderley\",\"Pharmacologie in vivo\",\"Recherche sur le cancer\"],\"articleSection\":[\"Mod\u00e8les d'oncologie\",\"oncologie\",\"pharmacologie in vivo\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/\",\"name\":\"Sygnature renforce ses capacit\u00e9s avec l'acquisition d'Alderley Oncology - Sygnature\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/AO-acquisition-scaled-1.jpg\",\"datePublished\":\"2020-06-03T12:15:41+00:00\",\"dateModified\":\"2026-02-11T09:47:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/AO-acquisition-scaled-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/AO-acquisition-scaled-1.jpg\",\"width\":2560,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sygnature renforce ses capacit\u00e9s avec l’acquisition d’Alderley Oncology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\",\"name\":\"pnpd-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"caption\":\"pnpd-admin\"},\"sameAs\":[\"http:\\\/\\\/www.sygnaturediscovery.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sygnature renforce ses capacit\u00e9s avec l'acquisition d'Alderley Oncology - Sygnature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/","og_locale":"fr_CA","og_type":"article","og_title":"Sygnature renforce ses capacit\u00e9s avec l'acquisition d'Alderley Oncology - Sygnature","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/","og_site_name":"Sygnature","article_published_time":"2020-06-03T12:15:41+00:00","article_modified_time":"2026-02-11T09:47:21+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/AO-acquisition-scaled-1.jpg","type":"image\/jpeg"}],"author":"pnpd-admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"pnpd-admin","Estimation du temps de lecture":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/#article","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/"},"author":{"name":"pnpd-admin","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448"},"headline":"Sygnature renforce ses capacit\u00e9s avec l’acquisition d’Alderley Oncology","datePublished":"2020-06-03T12:15:41+00:00","dateModified":"2026-02-11T09:47:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/"},"wordCount":665,"publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/AO-acquisition-scaled-1.jpg","keywords":["D\u00e9couverte de la signature","D\u00e9couverte de m\u00e9dicaments","Exp\u00e9riences pr\u00e9cliniques","Oncologie","Oncologie d'Alderley","Pharmacologie in vivo","Recherche sur le cancer"],"articleSection":["Mod\u00e8les d'oncologie","oncologie","pharmacologie in vivo"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/","name":"Sygnature renforce ses capacit\u00e9s avec l'acquisition d'Alderley Oncology - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/AO-acquisition-scaled-1.jpg","datePublished":"2020-06-03T12:15:41+00:00","dateModified":"2026-02-11T09:47:21+00:00","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/AO-acquisition-scaled-1.jpg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/AO-acquisition-scaled-1.jpg","width":2560,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/sygnature-renforce-ses-capacites-avec-lacquisition-dalderley-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Sygnature renforce ses capacit\u00e9s avec l’acquisition d’Alderley Oncology"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448","name":"pnpd-admin","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","caption":"pnpd-admin"},"sameAs":["http:\/\/www.sygnaturediscovery.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/comments?post=13906"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13906\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/13907"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=13906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=13906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/tags?post=13906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}